IRIS
PIRISI, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 15.385
NA - Nord America 14.977
AS - Asia 9.560
SA - Sud America 1.536
Continente sconosciuto - Info sul continente non disponibili 743
AF - Africa 364
OC - Oceania 24
AN - Antartide 1
Totale 42.590
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.480
RU - Federazione Russa 3.871
SG - Singapore 2.971
IE - Irlanda 2.775
IT - Italia 2.027
CN - Cina 1.980
DE - Germania 1.646
HK - Hong Kong 1.430
SE - Svezia 1.317
VN - Vietnam 1.310
FR - Francia 1.201
BR - Brasile 1.144
UA - Ucraina 943
IN - India 519
FI - Finlandia 492
GB - Regno Unito 377
BD - Bangladesh 287
CA - Canada 276
KR - Corea 252
AR - Argentina 160
ID - Indonesia 142
BJ - Benin 137
CZ - Repubblica Ceca 137
MX - Messico 120
PL - Polonia 119
TR - Turchia 108
AT - Austria 103
NL - Olanda 99
ZA - Sudafrica 88
JP - Giappone 86
ES - Italia 79
IQ - Iraq 78
IR - Iran 61
PK - Pakistan 50
BE - Belgio 49
EC - Ecuador 49
CL - Cile 45
CO - Colombia 39
LT - Lituania 37
VE - Venezuela 37
PH - Filippine 30
EG - Egitto 28
SA - Arabia Saudita 25
MA - Marocco 24
PE - Perù 24
TH - Thailandia 24
PY - Paraguay 22
TW - Taiwan 22
AU - Australia 21
CH - Svizzera 21
EU - Europa 20
MY - Malesia 19
UZ - Uzbekistan 18
JM - Giamaica 17
JO - Giordania 16
KE - Kenya 16
NP - Nepal 16
TN - Tunisia 16
AE - Emirati Arabi Uniti 15
DZ - Algeria 14
IL - Israele 14
TT - Trinidad e Tobago 13
RO - Romania 12
PT - Portogallo 11
AL - Albania 10
DO - Repubblica Dominicana 10
HN - Honduras 10
AZ - Azerbaigian 9
CR - Costa Rica 9
KZ - Kazakistan 9
NG - Nigeria 9
UY - Uruguay 9
GT - Guatemala 8
LB - Libano 8
MD - Moldavia 8
OM - Oman 8
BH - Bahrain 7
PR - Porto Rico 7
RS - Serbia 7
SN - Senegal 7
ET - Etiopia 5
GE - Georgia 5
LV - Lettonia 5
SV - El Salvador 5
SY - Repubblica araba siriana 5
BB - Barbados 4
BO - Bolivia 4
BY - Bielorussia 4
DK - Danimarca 4
HR - Croazia 4
LK - Sri Lanka 4
MN - Mongolia 4
MO - Macao, regione amministrativa speciale della Cina 4
PS - Palestinian Territory 4
XK - ???statistics.table.value.countryCode.XK??? 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
CI - Costa d'Avorio 3
GD - Grenada 3
GR - Grecia 3
Totale 41.794
Salva come PNG Salva come JPEG
Città #
Dublin 2.756
San Jose 1.667
Jacksonville 1.660
Hong Kong 1.410
Singapore 1.110
Ashburn 984
Council Bluffs 958
Dearborn 729
Beijing 626
Chandler 603
Moscow 445
Wilmington 432
Los Angeles 409
Ho Chi Minh City 396
Columbus 377
Lauterbourg 359
Novara 343
Princeton 332
Lawrence 331
Hanoi 283
San Mateo 251
Ann Arbor 241
New York 238
Buffalo 235
Munich 224
Piemonte 216
Seoul 207
Milan 201
Santa Clara 195
São Paulo 154
Cotonou 137
Houston 130
Andover 129
Orem 126
Dallas 116
Turin 115
Frankfurt am Main 112
Boardman 111
Warsaw 93
Jakarta 91
Helsinki 90
Chennai 89
Nuremberg 85
Montreal 78
Denver 75
Brno 73
Brooklyn 71
Vercelli 71
Woodbridge 71
London 69
Toronto 68
Redondo Beach 66
Bremen 65
Guangzhou 64
Atlanta 63
Phoenix 63
Tokyo 63
Nanjing 62
Johannesburg 61
Poplar 61
Dong Ket 60
Falkenstein 60
Chicago 58
Rome 58
Da Nang 55
Philadelphia 53
Tianjin 53
Turku 53
Hefei 52
Stockholm 52
Mexico City 51
Brussels 47
Amsterdam 46
Vienna 46
Boston 44
Haiphong 43
Mumbai 40
Seattle 40
Ankara 37
Düsseldorf 37
Shanghai 37
Hangzhou 36
Norwalk 35
Pardubice 34
Manchester 32
Kunming 29
Rio de Janeiro 29
Biên Hòa 28
San Francisco 28
Hải Dương 27
Kocaeli 27
Baghdad 25
Hillsboro 25
Paris 25
Dhaka 24
The Dalles 24
Bologna 23
Torino 23
Brasília 22
Curitiba 22
Totale 22.480
Salva come PNG Salva come JPEG
Nome #
Midterm functional sequelae and implications in rehabilitation after COVID19. A cross-sectional study 400
Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts 282
Fatality rate and predictors of mortality in an Italian cohort of hospitalized COVID-19 patients 263
Genistein and 17β-Estradiol Protect Hepatocytes from Fatty Degeneration by Mechanisms Involving Mitochondria, Inflammasome and Kinases Activation 235
Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C 232
Simple Parameters from Complete Blood Count Predict In-Hospital Mortality in COVID-19 204
Baseline Plasma Osteopontin Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients 196
Clinical Relevance of Liver Involvement in the Clinical Course of Systemic Sclerosis 194
Contribution of Atrial Fibrillation to In-Hospital Mortality in Patients With COVID-19 193
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort 181
Liver infection and COVID-19: the electron microscopy proof and revision of the literature 176
rs1801253 Gly/Gly carriage in the ADRB1 gene leads to unbalanced cardiac sympathetic modulation as assessed by spectral analysis of heart rate variability 175
Periodic clinical monitoring after liver transplantation 173
Association between red cell distribution width and response to methotrexate in rheumatoid arthritis 172
Gas6 as a predictor of esophageal varices in patients affected by hepatitis C virus related-chronic liver disease 171
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment 170
Change over time of COVID-19 hospital presentation in Northern Italy 169
Respiratory and Psychophysical Sequelae Among Patients With COVID-19 Four Months After Hospital Discharge 168
Testosterone Plasma Concentration is Associated with Insulin Resistance in Male Hypertensive Patients 167
Role of positron emission tomography in the assessment of disease burden and risk of relapse in patients affected by giant cell arteritis 165
B2-Lymphocyte responses to oxidative stress-derived antigens contribute to the evolution of nonalcoholic fatty liver disease (NAFLD) 165
Clinical outcome with different doses of low-molecular-weight heparin in patients hospitalized for COVID-19 163
Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial 162
Treatment failure after interferon-free treatment of hepatitis C as a clue of a yet undetected hepatocellular carcinoma 162
Levosimendan inhibits peroxidation in hepatocytes by modulating apoptosis/autophagy interplay. 162
Outcomes of COVID-19 patients treated with continuous positive airway pressure outside ICU 162
Relation among anti-rheumatic drug therapy, CD14(+)CD16(+) blood monocytes and disease activity markers (DAS28 and US7 scores) in rheumatoid arthritis: A pilot study. 160
On-target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi-centre, prospective study 160
Mid-term Psychiatric Outcomes of Patients Recovered From COVID-19 From an Italian Cohort of Hospitalized Patients 159
Long-term sequelae are highly prevalent one year after hospitalization for severe COVID-19 159
Gas6/TAM system: potential prognostic biomarker for Multiple Sclerosis 158
Role of beta-blockers in patients with COPD: current perspective. 158
Prognostic Markers in Hospitalized COVID-19 Patients: The Role of IP-10 and C-Reactive Protein 157
Anxiety, Stress and Depression in COVID-19 Survivors From an Italian Cohort of Hospitalized Patients: Results From a 1-Year Follow-Up 156
Interplay of PNPLA3 and HSD17B13 Variants in Modulating the Risk of Hepatocellular Carcinoma among Hepatitis C Patients 155
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study 152
One-Year Follow up of Noninvasive Respiratory Support in General Wards 152
CGRP Plasma Levels Correlate with the Clinical Evolution and Prognosis of Hospitalized Acute COVID-19 Patients 152
Antiviral treatment of hepatitis C improves glucose metabolism along the entire spectrum from normal glucose tolerance to diabetes 152
Pattern of emergency department referral during the Covid-19 outbreak in Italy 152
Acute decompensated heart failure in the emergency department: Identification of early predictors of outcome 151
Vitamin D in Systemic Sclerosis: A Review 150
Is cholecalciferol a potential disease modifying anti-rheumatic drug for the management of rheumatoid arthritis? 149
Decreased Gas6 and sAxl Plasma Levels Are Associated with Hair Loss in COVID-19 Survivors 148
Association between rheumatic diseases and cancer: results from a clinical practice cohort study 147
Inflammatory markers predict insulin sensitivity in active rheumatoid arthritis but not in psoriatic arthritis 147
Altered glucose metabolism rather than naive type 2 diabetes mellitus (T2DM) is related to vitamin D status in severe obesity. 145
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort 143
Validation of the Hepatoma Arterial Embolization Prognostic Score in European and Asian Populations and Proposed Modification. 143
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 143
Identification of mutations in circulating cell-free tumour DNA as a biomarker in hepatocellular carcinoma 143
"war to the knife" against thromboinflammation to protect endothelial function of COVID-19 patients 143
Detrimental Impact of Interferon-Based Regimens for Chronic Hepatitis C on Vitamin D/Parathyroid Hormone Homeostasis 143
17β-Oestradiol Protects from Hepatitis C Virus Infection through Induction of Type I Interferon 142
L’impatto del Long COVID è stato minore nella terza ondata della pandemia rispetto alla prima ondata in una popolazione italiana di 324 pazienti. 142
Higher Serum Monolaurin Is Associated with a Lower Risk of COVID-19: Results from a Prospective Observational Cohort Study 140
Oxidative Stress in Non-Alcoholic Fatty Liver Disease 140
Baseline Plasma Gas6 Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients 139
Gas6/TAM system: A key modulator of the interplay between inflammation and fibrosis 138
4. Association between release of tumor necrosis factor and response to interferon therapy in chronic hepatitis C 138
Analysis of beta1 and beta2-adrenergic receptors polymorphism in patients with apical ballooning cardiomyopathy 138
Evaluation of the red cell distribution width as a biomarker of early mortality in hepatocellular carcinoma 137
Integration of the cancer-related inflammatory response as a stratifying biomarker of survival in hepatocellular carcinoma treated with sorafenib 137
Red cell distribution width and platelet count as biomarkers of pulmonary arterial hypertension in patients with connective tissue disorders 137
First reported human case of meningitis by Staphylococcus condimenti 136
Role of Osteopontin as a Potential Biomarker of Pulmonary Arterial Hypertension in Patients with Systemic Sclerosis and Other Connective Tissue Diseases (CTDs) 136
Anti-envelope antibodies in anti-hepatitis C virus (HCV) positive patients with and without liver disease 135
Increased Levels of ICOS and ICOSL Are Associated to Pulmonary Arterial Hypertension in Patients Affected by Connective Tissue Diseases 135
Ultrasound-assessed visceral fat and associations with glucose homeostasis and cardiovascular risk in clinical practice 134
Post-COVID-19 sequelae are associated with sustained SARS-CoV-2-specific CD4+ immune responses 132
A nurse-led coaching intervention with home telemonitoring for patients with heart failure: Protocol for a feasibility randomized clinical trial 132
Gas6 as a putative noninvasive biomarker of hepatic fibrosis 132
Combined sequential use of HAP and ART scores to predict survival outcome and treatment failure following chemoembolization in hepatocellular carcinoma: A multi-center comparative study 132
Improvement of insulin sensitivity in diabetic and non diabetic patients with chronic hepatitis C treated with direct antiviral agents 132
AORTIC INVOLVEMENT IN A RETROSPECTIVE COHORT OF LARGE VESSEL VASCULITIS PATIENTS 132
17,β-estradiol inhibits hepatitis C virus mainly by interference with the release phase of its life cycle 131
Understanding protection from SARS-CoV-2 using metabolomics 131
A 28-Year-Old Woman with Ascites and Multiple Focal Spleen Lesions 131
Increased plasma levels of Gas6 and its soluble tyrosine kinase receptors Mer and Axl are associated with immunological activity and severity of lupus nephritis 131
Interaction between thrombin potential and age on early clinical outcome in patients hospitalized for COVID-19 130
Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment 129
Gas6/TAM system as potential biomarker for multiple sclerosis prognosis 129
(Letter) Membranoproliferative glomerulonephritis associated with Hepatitis C infection with no evidence of liver disease 129
Asymptomatic HBV and HCV carriers, bad breath and gengivitis 128
Eosinophilic gastroenteritis in pregnancy: A review of the literature 128
Diagnostic value of FibroTest with normal serum aminotransferases 127
Occult hepatitis B virus infection of peripheral blood mononuclear cells among treatment-naïve patients with chronic lymphocytic leukemia 127
Presenting features and early mortality from SARS-CoV-2 infection in cancer patients during the initial stage of the COVID-19 pandemic in Europe 127
Baseline plasma SARS-CoV-2 RNA detection predicts an adverse COVID-19 evolution in moderate to severe hospitalized patients 126
Influence of age on sex-related differences among patients with hepatitis C. 126
Liver stiffness, not fat liver content, predicts the length of QTc interval in patients with chronic liver disease 126
Recent advances in the pathophysiology, diagnosis and treatment of hereditary hemochromatosis and other iron overload syndromes 125
An unusual adverse reaction to iodine-based contrast agent. 124
A case of false positive troponin I in a patient affected by cryoglobulinemic vasculitis 124
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 124
Modelling hospital bed necessity for COVID-19 patients during the decline phase of the epidemic trajectory 124
A woman with anemia and a small bowel obstruction 123
Profiling the patients visiting the emergency room for musculoskeletal complaints: characteristics and outcomes 123
HSD17B13 and other liver fat-modulating genes predict development of hepatocellular carcinoma among HCV-positive cirrhotics with and without viral clearance after DAA treatment 123
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 122
Totale 15.303
Salva come PNG Salva come JPEG
Categoria #
all - tutte 208.662
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 208.662
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.178 0 58 458 227 111 28 167 79 196 104 282 468
2022/20235.509 501 219 276 151 299 444 165 234 2.839 34 226 121
2023/20242.590 140 340 151 77 393 74 490 134 54 86 249 402
2024/20255.275 135 64 260 144 146 333 523 545 1.196 491 390 1.048
2025/202617.677 778 666 1.146 2.451 1.713 1.239 2.654 2.903 1.265 1.293 969 600
2026/20271.944 766 1.178 0 0 0 0 0 0 0 0 0 0
Totale 42.590